Skip to main content

Medical Oncology

Ausgabe 3/2015

Inhalt (48 Artikel)

Original Paper

Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations

Akihiro Tamiya, Motohiro Tamiya, Takayuki Shiroyama, Nobuhiko Saijo, Takeshi Nakatani, Shojiro Minomo, Taisuke Tsuji, Naoko Takeuchi, Naoki Omachi, Kanako Kurata, Hidekazu. Suzuki, Norio Okamoto, Kyoichi Okishio, Tomonori Hirashima, Shinji Atagi

Original Paper

Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity

M. G. Alexandrakis, C. A. Pappa, M. Kokonozaki, A. Boula, R. Vyzoukaki, D. Staphylaki, A. Papadopoulou, N. Androulakis, G. Tsirakis, A. Sfiridaki

Original Paper

Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes

Weiliang Chen, Donghai Wang, Xinwen Du, Ying He, Songyu Chen, Qianqian Shao, Chao Ma, Bin Huang, Anjing Chen, Peng Zhao, Xun Qu, Xingang Li

Original Paper

CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer

Yingying Qian, Dong Pei, Ting Cheng, Changling Wu, Xiaolin Pu, Xiaofeng Chen, Yiqian Liu, Hong Shen, Weiwei Zhang, Yongqian Shu

Original Paper

The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas

Jiafeng Qi, Huiling Li, Nanbo Liu, Yutong Xing, Gang Zhou, Yao Wu, Yuanhang Liu, Wenxia Chen, Jie Yue, Bater Han, Shirong Kang, Xu Wu

Original Paper

Radiation sensitization with sodium nitrite in patients with brain metastases: a pilot randomized controlled trial

Seyed Mohammad Hosseini, Shole Arvandi, Sasan Razmjoo, Hodjatollah Shahbazian, Fakher Rahim, Tohid Rafie, Maedeh Barahman, Ali Bagheri

Original Paper

GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway

Fang Liang, Junmin Yue, Junyong Wang, Lijuan Zhang, Rui Fan, Hao Zhang, Qingsong Zhang

Original Paper

Acoustic radiation force impulse elastography for differentiation of benign and malignant thyroid nodules with concurrent Hashimoto’s thyroiditis

Bo-Ji Liu, Hui-Xiong Xu, Yi-Feng Zhang, Jun-Mei Xu, Dan-Dan Li, Xiao-Wan Bo, Xiao-Long Li, Le-Hang Guo, Xiao-Hong Xu, Shen Qu

Original Paper

Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2

Jie Gu, Feng-kai Xu, Guang-yin Zhao, Chun-lai Lu, Zong-wu Lin, Jian-yong Ding, Di Ge

Original Paper

Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience

R. Petrioli, G. Roviello, A. I. Fiaschi, L. Laera, Salvatora T. Miano, G. De Rubertis, G. Barbanti, V. Bianco, S. Brozzetti, E. Francini

Original Paper

Continuous, low-dose capecitabine for patients with recurrent colorectal cancer

Adriana Romiti, Concetta Elisa Onesti, Michela Roberto, Viola Barucca, Silverio Tomao, Chiara D’Antonio, Valeria Durante, Annalisa Milano, Rosa Falcone, Roberta Di Rocco, Riccardo Righini, Paolo Marchetti

Original Paper

The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia

Cemil Bilir, Huseyin Engin, Murat Can, Yasemin Bakkal Temi, Derya Demirtas

Original Paper

ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins

Lixia Bai, Rui Mao, Jintao Wang, Ling Ding, Shiwen Jiang, Chenfei Gao, Huijie Kang, Xiao Chen, Xuesong Sun, Juan Xu

Original Paper

Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma

Tianxiang Ge, Qiujin Shen, Ning Wang, Yurong Zhang, Zhouhong Ge, Wei Chu, Xiufang Lv, Fengbo Zhao, Weifeng Zhao, Jia Fan, Wenxin Qin

Original Paper

Whole genome expression profiling in chewing-tobacco-associated oral cancers: a pilot study

Sanjukta Chakrabarti, Shaleen Multani, Jyoti Dabholkar, Dhananjaya Saranath

Original Paper

The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis

Yaxiong Zhang, Wenfeng Fang, Yue Yan, Mengyao Wang, Shiyang Kang, Jin Sheng, Jianhua Zhan, Nan Chen, Shaodong Hong, Yunpeng Yang, Yuxiang Ma, Dacheng He, Tao Qin, Ting Zhou, Yanna Tang, Xiaobo He, Wenhua Liang, Li Zhang

Original Paper

CD40 expression and its prognostic significance in human gastric carcinoma

Jing Guo, Jia-Jia Xiao, Xiaoli Zhang, Kai-Xi Fan

Original Paper

Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study

Tongchun Xue, Fan Le, Rongxin Chen, Xiaoying Xie, Lan Zhang, Ningling Ge, Yi Chen, Yanhong Wang, Boheng Zhang, Shenglong Ye, Zhenggang Ren

Original Paper

CCR9–CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway

Baijun Li, Zhiwei Wang, Yonglong Zhong, Jiao Lan, Xiangwei Li, Hui Lin

Original Paper

OCH-mediated shift of Th1 and Th2 cytokines by NKT cells in mice with aplastic anemia

Xiaohong Qiao, Xiaotian Xie, Wei Shi, Jinqing Tang, Yuexia Shao, Fuxing Li

Original Paper

Differentiation of benign and malignant focal liver lesions: value of virtual touch tissue quantification of acoustic radiation force impulse elastography

Le-Hang Guo, Shu-Jun Wang, Hui-Xiong Xu, Li-Ping Sun, Yi-Feng Zhang, Jun-Mei Xu, Jian Wu, Hui-Jun Fu, Xiao-Hong Xu

Original Paper

p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ

Leina Ma, Jia Liu, Xinling Zhang, Jieqiong Qi, Wengong Yu, Yuchao Gu

Original Paper

Preoperative chemoradiotherapy with 5-fluorouracil and oxaliplatin for locally advanced rectal cancer: long-term results of a phase II trial

Luying Liu, Caineng Cao, Yuan Zhu, Dechuan Li, Haiyang Feng, Jialin Luo, Zhongzhu Tang, Peng Liu, Ke Lu, Haixing Ju, Na Zhang

Original Paper

Mechanical characterization of cervical squamous carcinoma cells by atomic force microscopy at nanoscale

Yong-xia Ding, Yuan Cheng, Quan-mei Sun, You-yi Zhang, Ke You, Yan-li Guo, Dong Han, Li Geng

Original Paper

Effect of baicalin-copper on the induction of apoptosis in human hepatoblastoma cancer HepG2 cells

Xiaoli Li, Kaili Zou, Jing Gou, Qin Du, Dejuan Li, Xiaoyan He, Zhubo Li

Original Paper

PinX1 inhibits cell proliferation, migration and invasion in glioma cells

Peng-Jin Mei, Yan-Su Chen, Ying Du, Jin Bai, Jun-Nian Zheng

Original Paper

The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma

Wei Qiu, Guangyi Wang, Xiaodong Sun, Junfeng Ye, Feng Wei, Xiaoju Shi, Guoyue Lv

Original Paper

Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patients

Lan Zhang, Ning-Lin Ge, Yi Chen, Xiao-Ying Xie, Xin Yin, Yu-Hong Gan, Bo-Heng Zhang, Ju-Bo Zhang, Rong-Xin Chen, Yan-Hong Wang, Sheng-Long Ye, Zheng-Gang Ren

Original Paper

A phase II study of arsenic trioxide in patients with relapsed or refractory malignant lymphoma

Hongli Zhao, Guoxun Sun, Desheng Kong, Yujing Zhang, Wudan Shi, Mingming Zhao, Luojia Hong, Zhenkui Qiao

Original Paper

Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer

Icro Meattini, Giulio Francolini, Vieri Scotti, Carla De Luca Cardillo, Sabrina Cappelli, Fiammetta Meacci, Ilaria Francesca Furfaro, Cristina Muntoni, Silvia Scoccianti, Beatrice Detti, Monica Mangoni, Jacopo Nori, Lorenzo Orzalesi, Massimiliano Fambrini, Simonetta Bianchi, Lorenzo Livi

Original Paper

CUGBP1 promotes cell proliferation and suppresses apoptosis via down-regulating C/EBPα in human non-small cell lung cancers

Haijiao Lu, Zhuang Yu, Shihai Liu, Lianhua Cui, Xiaozheng Chen, Ruyong Yao

Original Paper

VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer

Hui Li, Ziwei Wang, Wei Zhang, Kun Qian, Gang Liao, Wei Xu, Shouru Zhang

Original Paper

Downregulation of UPK1A suppresses proliferation and enhances apoptosis of bladder transitional cell carcinoma cells

Haiyan Zhu, Yuxin Tang, Xiangyang Zhang, Xianzhen Jiang, Yong Wang, Yu Gan, Jianfu Yang

Original Paper

Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma

Jianwei Zhang, Wenfeng Fang, Tao Qin, Yunpeng Yang, Shaodong Hong, Wenhua Liang, Yuxiang Ma, Hongyun Zhao, Yan Huang, Cong Xue, Peiyu Huang, Zhihuang Hu, Yuanyuan Zhao, Li Zhang

Short Communication

BUB1B promotes multiple myeloma cell proliferation through CDC20/CCNB axis

Ye Yang, Chunyan Gu, Chen Luo, Fei Li, Min Wang

Erratum

Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer

Li Li Lin, Wei Wang, ZhaoYang Hu, Li Wen Wang, Jing Chang, HanGuang Qian

Erratum

Erratum to: Slug signaling is up-regulated by CCL21/CCR7 to induce EMT in human chondrosarcoma

Guosong Li, Yanjun Yang, Siliang Xu, Lifeng Ma, Mingtang He, Ziqing Zhang

Erratum

Erratum to: The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy

Tulay Akman, Ilhan Oztop, Yasemin Baskin, Mahdi Akbarpour, Olcun Umit Unal, Utku Oflazoglu, Hulya Ellidokuz, Banu Lebe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.